08.21.13
Winnipeg, Manitoba, Canada-based Imris Inc., an image guided therapy solutions, has appointed R. Stephen Armstrong to the company’s board of directors. Armstrong currently serves as executive vice president and chief financial officer for Patterson Companies Inc., a medical supplies company focused on the dental and veterinary markets.
Armstrong has been with Patterson since 1999. He started his career at Ernst and Young LLP in 1973, and became an audit assurance partner in his 26-year tenure at the firm, primarily serving publicly-traded national and multinational clients. He is also a board member of printer company Delphax Technologies Inc. and is chair of its audit committee.
“Steve brings combined global medical products and financial insights to the Imris board of directors,” said David Graves, Imris’ chairman of the board. “His broad accounting and industry experience will make an impact on the board in our continued management and growth.”
Armstrong’s background includes extensive experience with U.S. Securities and Exchange Commission registration and reporting requirements, inventory accounting techniques, acquisition due diligence and reporting, corporate income tax, and stock compensation programs.
“I look forward to working closely with the Imirs board and management team,” Armstrong said. “The innovative Imirs technology has become firmly established in the intraoperative MRI [magnetic resonance imaging] market and, now with the approval of Visius iCT and other products in development, the company is poised for continued growth in the image guided therapy space.”
Visius iCT is a computed tomography specialized multifunctional surgical theater. It is a ceiling-mounted intraoperative system that can be moved from room to room for flexibility.
Armstrong will be based in Minnetonka, Minn., where Imris’ U.S. offices are located.
Armstrong has been with Patterson since 1999. He started his career at Ernst and Young LLP in 1973, and became an audit assurance partner in his 26-year tenure at the firm, primarily serving publicly-traded national and multinational clients. He is also a board member of printer company Delphax Technologies Inc. and is chair of its audit committee.
“Steve brings combined global medical products and financial insights to the Imris board of directors,” said David Graves, Imris’ chairman of the board. “His broad accounting and industry experience will make an impact on the board in our continued management and growth.”
Armstrong’s background includes extensive experience with U.S. Securities and Exchange Commission registration and reporting requirements, inventory accounting techniques, acquisition due diligence and reporting, corporate income tax, and stock compensation programs.
“I look forward to working closely with the Imirs board and management team,” Armstrong said. “The innovative Imirs technology has become firmly established in the intraoperative MRI [magnetic resonance imaging] market and, now with the approval of Visius iCT and other products in development, the company is poised for continued growth in the image guided therapy space.”
Visius iCT is a computed tomography specialized multifunctional surgical theater. It is a ceiling-mounted intraoperative system that can be moved from room to room for flexibility.
Armstrong will be based in Minnetonka, Minn., where Imris’ U.S. offices are located.